Nan Pharma Private Limited

Pharmaceutical company manufacturing and trading medicines, incorporated in 2010 in Visakhapatnam.

2010 | Visakhapatnam, Andhra Pradesh (India) | Active
Last Updated:

Nan Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 10 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 1.00 M
  • Revenue Growth 2.72%
  • Profit Growth 184.40%
  • Ebitda 236.49%
  • Net Worth 3.55%
  • Total Assets 9.43%

About Nan Pharma

Nan Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 2010 and has a history of 14 years and ten months. Its registered office is in Visakhapatnam, Andhra Pradesh, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹1.00 M.

Appala Nukala, Surya Girija, and Sundari Anupindi serve as directors at the Company.

Company Details

  • Location

    Visakhapatnam, Andhra Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232AP2010PTC069300

  • Company No.

    069300

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    05 Jul 2010

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Vijayawada

Industry

Pharma
Company report

Nan Pharma Private Limited

Explore comprehensive data for Nan Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Nan Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Appala Nukala Country flag representing In Director 05-Jul-2010Current
Surya Girija Country flag representing In Director 16-Jun-2014Current
Sundari Anupindi Country flag representing In Director 05-Jul-2010Current

Financial Performance of Nan Pharma.

Nan Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.72% increase. The company also saw a substantial improvement in profitability, with a 184.4% increase in profit. The company's net worth moved up by a moderate rise of 3.55%.

Nan Pharma revenue growth over time
Nan Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.72%
Revenue from Operations
8.71%
Total Assets
9.43%
Profit or Loss
184.40%
Net Worth
3.55%
EBITDA
236.49%

What is the Ownership and Shareholding Structure of Nan Pharma?

In 2019, Nan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • The Karnataka Bank Limited : 0.10 Cr

Latest Charge Details

DateLenderAmountStatus
21 Sep 2012The Karnataka Bank Limited₹1.00 MOpen

How Many Employees Work at Nan Pharma?

Unlock and access historical data on people associated with Nan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Nan Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nan Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nan Pharma

Recent activity within the organization

  • Annual General Meeting

    Nan Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

  • Balance Sheet

    Nan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada.

  • Director Appointment

    Surya Venkata Satya Ganti Girija was appointed as a Director was appointed as a Director on 16 Jun 2014 & has been associated with this company since 10 years 10 months .

  • Charges

    A charge with The Karnataka Bank Limited amounted to Rs. 1.00 M with Charge ID 10383562 was registered on 21 Sep 2012.

  • Director Appointment

    Appala Narasimha Murthy Nukala was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 14 years 10 months .

  • Director Appointment

    Sundari Anupindi was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 14 years 10 months .

Frequently asked questions

  • What is the Incorporation or founding date of Nan Pharma Private Limited?

    Nan Pharma Private Limited was incorporated on 05 Jul 2010.

  • What is authorized share capital and paid-up capital of Nan Pharma Private Limited?

    The authorized share capital of Nan Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Nan Pharma Private Limited?

    Currently 3 directors are associated with Nan Pharma Private Limited.

    • Appala Narasimha Murthy Nukala
    • Surya Venkata Satya Ganti Girija
    • Sundari Anupindi

  • What is the registered address of Nan Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Nan Pharma Private Limited is Door No.43-9-163 S Towers T N Colony, Dondaparthy India, Visakhapatnam, Andhra Pradesh, 530016.

  • What is the corporate identification number (CIN) and company number of Nan Pharma Private Limited?

    The corporate identification number (CIN) of Nan Pharma Private Limited is U24232AP2010PTC069300 and the company number is 069300 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Nan Pharma Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Nan Pharma Private Limited has risen by 2.72%.

  • What change has been observed in the net worth of Nan Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Nan Pharma Private Limited has experienced an upsurge of 3.55%.

  • What are the total open charges for Nan Pharma Private Limited?

    As per the financial statements for fiscal Year 2020, The total open charges for Nan Pharma Private Limited amount to ₹ 1.00 M.

  • When was the last Balance Sheet of Nan Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Nan Pharma Private Limited was filed with the ROC on 31 Mar 2022.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development